Specimen Validity Testing: Protecting the Integrity of Workplace Drug Testing

Mid-South Drug Testing | Memphis, TN & Paragould, ARSource: National Laboratory Certification Program (NLCP), Drug Testing Matters (2025)

Workplace drug testing is only effective if the specimen being tested is authentic. According to the National Laboratory Certification Program (NLCP), specimen validity testing (SVT) remains one of the most important safeguards against drug test tampering.

For employers, this is not just laboratory science — it is a compliance and liability issue.

What Is Specimen Validity Testing?

Specimen validity testing is designed to detect attempts to “beat the test.” Laboratories use SVT to determine whether a urine specimen has been:

• Adulterated (chemically altered)

• Substituted (replaced with synthetic or another person’s urine)

• Diluted (watered down to lower drug concentrations)

Federal Mandatory Guidelines require SVT in urine drug testing programs to protect workplace safety and ensure results are legally defensible.

Why Employers Should Care

Attempts to subvert drug testing are not uncommon. Recent monitoring of online discussions shows that substitution using synthetic urine has become one of the most frequently discussed methods of beating a drug test.

If specimen tampering goes undetected, employers face:

• Increased safety risk

• Regulatory exposure

• Failed DOT audits

• Legal liability

• Workers’ compensation complications

For safety-sensitive industries, the consequences can be significant.

How Tampering Is Detected

Laboratories evaluate markers such as:

• pH levels

• Creatinine concentration

• Specific gravity

• Oxidizing agents

Abnormal values may indicate dilution, substitution, or adulteration. However, not all abnormal results prove tampering. Medical or biological factors can also produce unusual findings, which is why Medical Review Officer (MRO) oversight is essential.

The First Line of Defense: Proper Collection

The most effective protection against substitution happens at the collection site. Federal collection procedures require:

• Bluing agents in toilets

• Secured water sources

• Temperature checks

• Pocket checks

• Visual inspection of specimens

Collectors must remain vigilant, especially given the increasing availability of synthetic urine products designed to mimic authentic specimens.

What This Means for DOT and Non-DOT Employers

DOT-regulated programs must follow federal Mandatory Guidelines, including SVT requirements. Non-DOT employers should apply similar standards to maintain defensible and consistent workplace policies.

As testing methods evolve, so do subversion strategies. Employers must ensure their testing provider:

• Follows current federal guidelines

• Uses compliant laboratory partners

• Provides proper collection oversight

• Offers supervisor and DER training

• Supports policy review and compliance audits

Mid-South Drug Testing remains committed to protecting the integrity of workplace drug testing programs across Tennessee, Arkansas, Mississippi, and Missouri.

If you have questions about dilute results, invalid specimens, tampering procedures, or DOT compliance, contact Mid-South Drug Testing at (901) 320-9295 or (870) 215-0025 or visit https://midsouthdrugtesting.com.